[ Price : $8.95]
FDA warns Steiner Biotechnology about violations in its conduct of nonclinical laboratory studies.[ Price : $8.95]
FDA proposes to reclassify two types of hepatitis C diagnostic tests from Class 3 to Class 2 with special controls.[ Price : $8.95]
Federal Register notice: FDA amends certain medical device regulations to accurately reflect the devices exempted from premarket n...[ Price : $8.95]
FDA asks manufacturers of all Rx and OTC ranitidine products to remove them from the market due to NDMA contamination.[ Price : $8.95]
Federal Register notice: FDA amends its medical device regulations to reflect changes to CDRHs organizational structure, including...[ Price : $8.95]
Federal Register notice: FDA amends the animal drug regulations to reflect application-related actions made during the first quart...[ Price : $8.95]
The Wiley Rein law firm asks FDA to rescind its approval of OTC status for diclofenac gel 1% unless revisions are made to the labe...[ Price : $8.95]
Two stakeholders raise concerns with proposed direct-to-consumer advertising research into celebrity endorsements.